The pickup, which was made through Wi-LAN’s wholly owned subsidiary, Automation Middleware Solutions, is a sidestep for the company, which normally focuses on intellectual property around wireless communications. But Wi-LAN has shown signs of branching out. Last summer the company acquired a portfolio of medical patents that relate to Stent technology, the company’s first foray into medical technology.
The company now has more than 40 portfolios available for licensing.
“This portfolio has already generated licence agreements worth many tens of millions of dollars, and key patents in the portfolio have been affirmed by multiple patent office actions,” said CEO Jim Skippen. “We are excited to have the opportunity to license this quality patent portfolio to the majority of the market that remains unlicensed.”
Wi-LAN says believes that technology in the portfolio is applicable to a range of industrial automation systems, including manufacturing robots, actuators and computer numerical control machines
At press time, shares of Wi-LAN on the TSX were up 2.7% to $2.65.
Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]
Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]
Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]
A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]
Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]
The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]